Literature DB >> 5874531

Control of aspartate transcarbamylase activity in type 5 adenovirus-infected HeLa cells.

R A Consigli, H S Ginsberg.   

Abstract

Consigli, Richard A. (University of Pennsylvania, Philadelphia), and Harold S. Ginsberg. Control of aspartate transcarbamylase activity in type 5 adenovirus-infected HeLa cells. J. Bacteriol. 87:1027-1033. 1964.-Type 5 adenovirus infection induces increased aspartate transcarbamylase (ATCase) activity during the period of magnified nucleic acid biosynthesis. Increased activity can be prevented by addition of pyrimidines to the culture medium. ATCase in HeLa cells is regulated by feedback inhibition, and purified enzyme can be inhibited in vitro by cytidine triphosphate (CTP). The enzyme from infected cells has a pH optimum, maximal velocity, and K(m) for aspartate distinctly different from ATCase from control cells. However, heating of ATCase from uninfected cells converts the enzyme so that its characteristics are identical with enzyme from infected cells. Conversely, addition of CTP to ATCase from infected cells changes the characteristics of the enzyme so that they are the same as those of enzyme from uninfected cells. The evidence presented suggests that increased nucleic acid biosynthesis in infected cells initiates a release from feedback inhibition and increases ATCase activity by reducing the concentration of pyrimidines and purines in the acid-soluble pool.

Entities:  

Mesh:

Substances:

Year:  1964        PMID: 5874531      PMCID: PMC277141          DOI: 10.1128/jb.87.5.1027-1033.1964

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Feedback mechanisms influencing purine ribotide synthesis.

Authors:  J B WYNGAARDEN; H R SILBERMAN; J H SADLER
Journal:  Ann N Y Acad Sci       Date:  1958-10-13       Impact factor: 5.691

2.  Metabolic effects of 6-thioguanine. II. Biosynthesis of nucleic acid purines in vivo and in vitro.

Authors:  A C SARTORELLI; G A LEPAGE
Journal:  Cancer Res       Date:  1958-12       Impact factor: 12.701

3.  Purine metabolism in bacteria. V. Feed-back inhibition.

Authors:  J S GOTS
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

4.  Nutrition of bacteria and fungi.

Authors:  B MAGASANIK
Journal:  Annu Rev Microbiol       Date:  1957       Impact factor: 15.500

5.  The potential for the formation of a biosynthetic enzyme in Escherichia coli.

Authors:  L GORINI; W K MAAS
Journal:  Biochim Biophys Acta       Date:  1957-07

6.  Control by uracil of formation of enzymes required for orotate synthesis.

Authors:  R A YATES; A B PARDEE
Journal:  J Biol Chem       Date:  1957-08       Impact factor: 5.157

7.  Pyrimidine biosynthesis in Escherichia coli.

Authors:  A B PARDEE; R A YATES
Journal:  J Biol Chem       Date:  1956-08       Impact factor: 5.157

8.  Control of pyrimidine biosynthesis in Escherichia coli by a feed-back mechanism.

Authors:  A B PARDEE; R A YATES
Journal:  J Biol Chem       Date:  1956-08       Impact factor: 5.157

9.  Activity of aspartate transcarbamylase in uninfected and type 5 adenovirus-infected HeLa cells.

Authors:  R A Consigli; H S Ginsberg
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

10.  Purine metabolism in bacteria. III. Accumulation of a new pentose-containing arylamine by a purine-requiring mutant of Escherichia coli.

Authors:  S H LOVE; J S GOTS
Journal:  J Biol Chem       Date:  1955-02       Impact factor: 5.157

View more
  4 in total

1.  Thymidine kinase in rat liver during development.

Authors:  H G Klemperer; G R Haynes
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

2.  PIK3CA mutant tumors depend on oxoglutarate dehydrogenase.

Authors:  Nina Ilic; Kıvanç Birsoy; Andrew J Aguirre; Nora Kory; Michael E Pacold; Shambhavi Singh; Susan E Moody; Joseph D DeAngelo; Nicole A Spardy; Elizaveta Freinkman; Barbara A Weir; Aviad Tsherniak; Glenn S Cowley; David E Root; John M Asara; Francisca Vazquez; Hans R Widlund; David M Sabatini; William C Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 3.  A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses.

Authors:  Yucheng Zheng; Shiliang Li; Kun Song; Jiajie Ye; Wenkang Li; Yifan Zhong; Ziyan Feng; Simeng Liang; Zeng Cai; Ke Xu
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

4.  Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.

Authors:  Livia Vastag; Emre Koyuncu; Sarah L Grady; Thomas E Shenk; Joshua D Rabinowitz
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.